Clinical Trials Directory

Trials / Unknown

UnknownNCT06267170

A Multicenter, Real-world Study of Adebrelimab in the Treatment of Extensive Stage Small Cell Lung Cancer

A Multicenter, Real-world Study of Adebrelimab in the Treatment of Extensive Stage

Status
Unknown
Phase
—
Study type
Observational
Enrollment
288 (estimated)
Sponsor
Henan Cancer Hospital · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This study collected data on patients with extensive stage small cell lung cancer treated with Adebrelimab to investigate its safety and efficacy

Conditions

Interventions

TypeNameDescription
DRUGAdebrelimabTreatment with adbelizumab

Timeline

Start date
2024-02-25
Primary completion
2025-02-25
Completion
2026-02-25
First posted
2024-02-20
Last updated
2024-02-20

Source: ClinicalTrials.gov record NCT06267170. Inclusion in this directory is not an endorsement.

A Multicenter, Real-world Study of Adebrelimab in the Treatment of Extensive Stage Small Cell Lung Cancer (NCT06267170) · Clinical Trials Directory